05/24/2024
KUR NEWS - Dallas, TX - Earlier this year, Michelle Saya joined the KUR International Team as Vice President of Compliance. Michelle brings a wealth of expertise to the role, promising to fortify the company’s commitment to compliance excellence.
Prior to joining KUR International, Michelle worked as an Assistant Director – Office of Research Integrity and Protections in Syracuse University where she led forward-thinking support including effectively managing all facets of ClinicalTrials.gov for NIH-funded research studies. Michelle was also the Chief Compliance Officer position for Research at Suny Update Medical University managing the Human Subject Protection Program. There, she was also a member of their Institutional Review Board (IRB).
“As Vice President of Compliance, Michelle assumes a pivotal role in shaping the company's strategic direction and fostering a culture of integrity and accountability. With Michelle at the helm, the organization is well-positioned to navigate the complexities of the regulatory landscape and emerge as a beacon of compliance best practices in its industry,” expressed Adam Maciak, Executive Officer and Founder of KUR International and all its entities.
In welcoming Michelle Saya as Vice President of Compliance, KUR not only celebrates her remarkable achievements but also embraces the invaluable expertise and leadership she brings to the organization that will allow us to embark on a journey towards greater compliance maturity, resilience and success.
KUR Research is a nationwide clinical research site management organization that began its journey as the first community-based investigative site network in urgent care centers. Nearly ten years later, with a proven track record of success from hundreds of clinical trials, KUR strives to make progress possible by continuing to partner with local community-based, established physician offices and by delivering a seamless and superior experience in the advancement of clinical research through consistently delivering reliable results and quality data. KUR has seasoned experts in the field of clinical trials and what separates the company from everyone else is their experience and commitment to staying current with the ever-changing clinical research environment and recognizing the impact of such research with physicians. The company’s corporate office is located in Dallas, Texas with team members working remotely across the United States and in India. KUR’s clinical trials are currently conducted at over 20 urgent care and private practice locations nationwide. For more information about KUR Research, visit www.kurr.com.
(When Michelle was Upstate’s institutional review board administrator, she was featured on Upstate Medical University’s “Informed Patient Podcast” in 2022. To listen, go to https://lnkd.in/g8eUe-42)